These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37461192)

  • 1. Population Pharmacokinetic Analysis of Brexpiprazole to Support its Indication and Dose Selection in Adolescents With Schizophrenia.
    Wang Y; Wang X; Larsen F; Cahill D; Zoubroulis A; Ward C; Kohegyi E; Raoufinia A
    J Clin Pharmacol; 2023 Nov; 63(11):1290-1299. PubMed ID: 37461192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brexpiprazole Pharmacokinetics in CYP2D6 Poor Metabolizers: Using Physiologically Based Pharmacokinetic Modeling to Optimize Time to Effective Concentrations.
    Elmokadem A; Bruno CD; Housand C; Jordie EB; Chow CR; Lesko LJ; Greenblatt DJ
    J Clin Pharmacol; 2022 Jan; 62(1):66-75. PubMed ID: 34328221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Safety of Brexpiprazole Following Multiple-Dose Administration to Japanese Patients With Schizophrenia.
    Ishigooka J; Iwashita S; Higashi K; Liew EL; Tadori Y
    J Clin Pharmacol; 2018 Jan; 58(1):74-80. PubMed ID: 28750151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of Treatment.
    Bruno CD; Elmokadem A; Housand C; Jordie EB; Chow CR; Laughren TP; Greenblatt DJ
    J Clin Pharmacol; 2022 Jan; 62(1):55-65. PubMed ID: 34339048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brexpiprazole.
    Markovic M; Gallipani A; Patel KH; Maroney M
    Ann Pharmacother; 2017 Apr; 51(4):315-322. PubMed ID: 28228056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long-term study (Secondary Publication).
    Ishigooka J; Usami T; Iwashita S; Kojima Y; Matsuo S
    Neuropsychopharmacol Rep; 2020 Jun; 40(2):122-129. PubMed ID: 32297486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brexpiprazole: A Review in Schizophrenia.
    Garnock-Jones KP
    CNS Drugs; 2016 Apr; 30(4):335-42. PubMed ID: 27023789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder.
    Kalaria SN; Farchione TR; Uppoor R; Mehta M; Wang Y; Zhu H
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S117-S124. PubMed ID: 34185904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study.
    Fleischhacker WW; Hobart M; Ouyang J; Forbes A; Pfister S; McQuade RD; Carson WH; Sanchez R; Nyilas M; Weiller E
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):11-21. PubMed ID: 27566723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brexpiprazole for the Treatment of Schizophrenia: A Review of this Novel Serotonin-Dopamine Activity Modulator.
    McEvoy J; Citrome L
    Clin Schizophr Relat Psychoses; 2016; 9(4):177-86. PubMed ID: 26757416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brexpiprazole for the treatment of schizophrenia.
    Hsu WY; Lane HY; Lin CH
    Expert Opin Pharmacother; 2017 Feb; 18(2):217-223. PubMed ID: 27997809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6-week, randomized, double-blind, placebo-controlled study.
    Ishigooka J; Iwashita S; Tadori Y
    Psychiatry Clin Neurosci; 2018 Sep; 72(9):692-700. PubMed ID: 29774628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study.
    Correll CU; Shi L; Weiss C; Hobart M; Eramo A; Duffy RA; Weiller E; Baker RA
    CNS Spectr; 2019 Oct; 24(5):507-517. PubMed ID: 30306884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia.
    Kane JM; Skuban A; Hobart M; Ouyang J; Weiller E; Weiss C; Correll CU
    Schizophr Res; 2016 Jul; 174(1-3):93-98. PubMed ID: 27188270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between previous high-dose antipsychotic therapy and brexpiprazole discontinuation after the initiation of brexpiprazole in patients with schizophrenia or schizoaffective disorder.
    Yoshimura Y; Shimizu H; Yamashita R; Washida K; Takeda T; Aoki S
    Int Clin Psychopharmacol; 2020 Mar; 35(2):98-104. PubMed ID: 31743231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study.
    Citrome L; Ota A; Nagamizu K; Perry P; Weiller E; Baker RA
    Int Clin Psychopharmacol; 2016 Jul; 31(4):192-201. PubMed ID: 26963842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brexpiprazole in the treatment of schizophrenia and agitation in Alzheimer's disease.
    Stummer L; Markovic M; Maroney M
    Neurodegener Dis Manag; 2020 Aug; 10(4):205-217. PubMed ID: 32618483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brexpiprazole for treatment of schizophrenia: a critical literature study].
    Spoelstra SK; Baas CAJ; Knegtering H
    Tijdschr Psychiatr; 2021; 63(1):48-55. PubMed ID: 33537974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
    Yan T; Greene M; Chang E; Houle CR; Waters HC; Tarbox MH; Broder MS
    Clin Ther; 2020 Jan; 42(1):77-93. PubMed ID: 31928831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.